Cytodyn Inc (CYDY)

[DonDonDonDon]

"All-cause mortality among critically ill patients was 28% (12/43) with leronlimab + SoC

and 37% (7/19) with placebo + SoC

at day 28 (Table4-6).

This
is approximately a 24% relative reduction in mortality."

The numbers are Tiny Tiny -- such that
ONE patient JUST ONE out of 19 makes a difference.

6/19 in the placebo group would have been 31.5%,

Which when you consider 19 patients its simply NOT different from 28 %

If the whole improvement comes down to one patient, it's pretty much impossible to rule out chance.

This is a nothing. An absolute nothing.

Mic drop